Third-trimester repeat HIV testing: it is time we make it universal
- PMID: 33932342
- DOI: 10.1016/j.ajog.2021.04.250
Third-trimester repeat HIV testing: it is time we make it universal
Abstract
Since the 1990s, perinatal transmission of HIV has decreased substantially, largely as a result of improved detection secondary to routine HIV screening in pregnancy and the use of antiretroviral therapy. However, despite reductions in HIV transmission, elimination of perinatal transmission, defined as an incidence of perinatal HIV infection of <1 per 100,000 live births and a transmission rate of <1%, remains elusive. An estimated 80% of perinatal transmissions occur after 36 weeks' gestation, which highlights the importance of diagnosis and treatment of maternal HIV infection before the highest-risk period for perinatal transmission. With timely identification of seroconversion, intrapartum and neonatal interventions can lower the risk of perinatal transmission from 25% to 10%, substantially reducing perinatal transmission events. The American College of Obstetricians and Gynecologists and the Centers for Disease Control and Prevention recommend that routine HIV testing be performed in all pregnancies, as early in the prenatal course as possible. Third-trimester repeat testing is only recommended for individuals known to be at high risk of acquiring HIV (ie, those who are incarcerated; who reside in jurisdictions with elevated HIV incidence; who are receiving care in facilities that have an HIV incidence in pregnant women > 1 per 1000 per year; or have signs or symptoms of acute HIV). However, among reproductive-age women, heterosexual intercourse is the most common mode of HIV transmission, and the risk of HIV seroconversion is greater during pregnancy than outside of pregnancy. Furthermore, state statutes for HIV testing in pregnancy are largely lacking. In this clinical opinion, we reviewed the evidence in support of universal third-trimester repeat HIV testing in pregnancy using a successful state-mandated testing program in Illinois. In addition, we provided clinical recommendations to further reduce missed perinatal transmission cases by implementing universal third-trimester repeat testing, obtaining hospital buy-in, monitoring testing adherence, bridging communications across multidisciplinary teams, and engaging clinicians in advocacy work.
Keywords: HIV testing; advocacy; neonatal HIV; perinatal HIV transmission; prenatal HIV testing; universal HIV testing.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
ACOG Committee Opinion No. 752: Prenatal and Perinatal Human Immunodeficiency Virus Testing.Obstet Gynecol. 2018 Sep;132(3):e138-e142. doi: 10.1097/AOG.0000000000002825. Obstet Gynecol. 2018. PMID: 30134428 Clinical Trial.
-
ACOG Committee Opinion No. 752 Summary: Prenatal and Perinatal Human Immunodeficiency Virus Testing.Obstet Gynecol. 2018 Sep;132(3):805-806. doi: 10.1097/AOG.0000000000002829. Obstet Gynecol. 2018. PMID: 30134421
-
Committee opinion no: 635: Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations.Obstet Gynecol. 2015 Jun;125(6):1544-1547. doi: 10.1097/01.AOG.0000466370.86393.d2. Obstet Gynecol. 2015. PMID: 26000543
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. doi: 10.1002/14651858.CD003510.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. PMID: 17253490 Updated. Review.
Cited by
-
Adherence to Sexually Transmitted Infection Screening in Pregnancy.J Womens Health (Larchmt). 2023 Jun;32(6):652-656. doi: 10.1089/jwh.2022.0409. Epub 2023 Apr 20. J Womens Health (Larchmt). 2023. PMID: 37083421 Free PMC article.
-
Identifying barriers and facilitators of the inclusion of pregnant individuals in hepatitis C treatment programs in the United States.PLoS One. 2022 Nov 18;17(11):e0277987. doi: 10.1371/journal.pone.0277987. eCollection 2022. PLoS One. 2022. PMID: 36399489 Free PMC article.
-
Testing for HIV Increases the Odds of Correct Fetal Ultrasound Result.Trop Med Infect Dis. 2022 Sep 13;7(9):242. doi: 10.3390/tropicalmed7090242. Trop Med Infect Dis. 2022. PMID: 36136653 Free PMC article.
-
Disparities in state-mandated third-trimester testing for syphilis.Am J Obstet Gynecol MFM. 2022 May;4(3):100595. doi: 10.1016/j.ajogmf.2022.100595. Epub 2022 Feb 15. Am J Obstet Gynecol MFM. 2022. PMID: 35176505 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical